✨ Free AI Report
Contego Medical Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Contego Medical Inc.
Company Research

Contego Medical Inc.: Business Overview, Financials & Competitive Analysis

Contego Medical Inc. scores 7/10 on the AskCyborg Cyborg Score (Strong). Well-positioned vascular device specialist with recent FDA approval and compelling clinical data, backed by solid funding, but facing competition from larger medtech incumbents. Contego demonstrates strong regulatory momentum (FDA PMA approval in October 2024) and meaningful clinical validation. The company has secured $66M in Series D funding and maintains.

What is Contego Medical Inc.'s industry? Contego Medical Inc. (contegomedical.com) operates in Cardiovascular Devices. AskCyborg classifies Contego Medical Inc. under Cardiovascular Devices in its company registry.

Contego Medical develops devices designed to improve patient outcomes and procedural efficiency during revascularization treatment for carotid and peripheral vascular disease. Founded in 2005 and based in Raleigh, Nor...

7/ 10Strong

Cyborg Score thesis

Well-positioned vascular device specialist with recent FDA approval and compelling clinical data, backed by solid funding, but...

Read the full analyst-debate transcript →
Industry Cardiovascular Devices
5 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 21, 2026
AI-Verified Research
30+ Page Report

Get the Latest Contego Medical Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Contego Medical Inc.

AskCyborg analysts argue the bull and bear cases for Contego Medical Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Contego Medical Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Contego Medical Inc. Overview

Pro stress-test →

Contego Medical develops devices designed to improve patient outcomes and procedural efficiency during revascularization treatment for carotid and peripheral vascular disease. Founded in 2005 and based in Raleigh, North Carolina, the company specializes in integrated embolic protection systems that simplify complex vascular procedures.

Strategic Profile

Pro stress-test →

In October 2024, the company achieved FDA premarket approval (PMA) for the Neuroguard IEP® System, a unique 3-in-1 carotid stenting system. Contego Medical has raised $66M in funding and operates as a Series D company, positioning itself as a specialist in vascular device innovation with a portfolio of FDA-cleared and CE-marked products.

Competitive Landscape

Pro stress-test →

Top competitors include SMT, Aortyx, and Thrombolex. Contego competes in the vascular embolic protection and carotid stenting segment against both specialized device makers and larger medtech platforms. The company's differentiation rests on integrated multi-functional device design and recent regulatory clearances, though it faces entrenched competition from larger players with broader distribution networks.

Industry Context

Contego Medical Inc. operates in Cardiovascular Devices.

Key facts

Founded: 2005 · Headquarters: Raleigh, North Carolina · Employees: 50 · Revenue: $5M

What the analysts stress-tested

The top findings that survived the multi-agent debate for Contego Medical Inc..

  • Achieved FDA PMA approval (October 2024) for flagship Neuroguard IEP® System after successful PERFORMANCE II clinical trial demonstrating lowest reported 1-year event rates in any adequately powered multicenter carotid revascularization study
  • Pioneering 3-in-1 integrated design that combines stent, dilation balloon, and embolic filter in single device, reducing procedure steps and improving safety versus traditional systems
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • October 2024FDA premarket approval (PMA) granted for Neuroguard IEP® System carotid stenting platform
  • August 2024Chief Medical Officer Mitchell J. Silver, D.O., FACC joined to lead clinical strategy and commercialization
  • +2 moreTrack every material event for Contego Medical Inc. as it happens. Explore monitoring →
Get alerted when Contego Medical Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Neuroguard (Carotid Stenting)Carotid stenting and embolic protection systems→Acculink Carotid Stent SystemFDA-approved carotid stenting platform→Carotid Stenting SystemsBroad vascular intervention portfolio including carotid systems→Thrombectomy DevicesThrombectomy and embolic protection platforms→Vascular Embolic ProtectionAortic and vascular intervention devices→

Compare Contego Medical Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Contego Medical Inc. operates in Cardiovascular Devices. See how the rest of the sector scores on the Cyborg framework.

Browse Cardiovascular Devices research →
NEW · MCP server

Ask your AI assistant about Contego Medical Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Contego Medical Inc. and its top competitor on Cyborg Score”
“What did Contego Medical Inc. do this quarter?”
“Is Contego Medical Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Contego Medical Inc. do?+
Contego Medical develops devices designed to improve patient outcomes and procedural efficiency during revascularization treatment for carotid and peripheral vascular disease. Founded in 2005 and based in Raleigh, Nor...
What is Contego Medical Inc.'s Cyborg Score?+
Contego Medical Inc. has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Contego Medical Inc.'s main competitors?+
Named competitors include Neuroguard (Carotid Stenting), Acculink Carotid Stent System, Carotid Stenting Systems, Thrombectomy Devices. The full competitive landscape is in the AskCyborg report.
How can I get the full Contego Medical Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Contego Medical Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Contego Medical Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.